Loading clinical trials...
Loading clinical trials...
Phase IIb Open-label Trial of SUBA™-Itraconazole in Subjects With Basal Cell Carcinoma Nevus Syndrome (BCCNS)
Conditions
Interventions
SUBA-Itraconazole
Locations
5
United States
Dermatology Specialists, Inc
Oceanside, California, United States
Ameriderm Research
Ormond Beach, Florida, United States
Grekin Skin Institute
Warren, Michigan, United States
Stony Brook University
East Setauket, New York, United States
Penn State Hershey Medical Center
Hershey, Pennsylvania, United States
Start Date
August 7, 2015
Primary Completion Date
March 1, 2019
Completion Date
March 1, 2019
Last Updated
August 5, 2020
Lead Sponsor
HedgePath Pharmaceuticals, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions